1. Home
  2. USNA vs FTRE Comparison

USNA vs FTRE Comparison

Compare USNA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • FTRE
  • Stock Information
  • Founded
  • USNA 1992
  • FTRE 1996
  • Country
  • USNA United States
  • FTRE United States
  • Employees
  • USNA N/A
  • FTRE N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • FTRE Medical Specialities
  • Sector
  • USNA Health Care
  • FTRE Health Care
  • Exchange
  • USNA Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • USNA 461.9M
  • FTRE 469.0M
  • IPO Year
  • USNA 1996
  • FTRE N/A
  • Fundamental
  • Price
  • USNA $29.51
  • FTRE $6.15
  • Analyst Decision
  • USNA Hold
  • FTRE Hold
  • Analyst Count
  • USNA 1
  • FTRE 11
  • Target Price
  • USNA $36.00
  • FTRE $18.00
  • AVG Volume (30 Days)
  • USNA 225.3K
  • FTRE 2.4M
  • Earning Date
  • USNA 04-22-2025
  • FTRE 05-12-2025
  • Dividend Yield
  • USNA N/A
  • FTRE N/A
  • EPS Growth
  • USNA N/A
  • FTRE N/A
  • EPS
  • USNA 1.82
  • FTRE N/A
  • Revenue
  • USNA $876,242,000.00
  • FTRE $2,696,400,000.00
  • Revenue This Year
  • USNA $13.04
  • FTRE N/A
  • Revenue Next Year
  • USNA $7.36
  • FTRE $3.32
  • P/E Ratio
  • USNA $16.36
  • FTRE N/A
  • Revenue Growth
  • USNA N/A
  • FTRE N/A
  • 52 Week Low
  • USNA $23.10
  • FTRE $4.77
  • 52 Week High
  • USNA $49.78
  • FTRE $37.24
  • Technical
  • Relative Strength Index (RSI)
  • USNA 64.50
  • FTRE 46.07
  • Support Level
  • USNA $27.82
  • FTRE $5.40
  • Resistance Level
  • USNA $29.84
  • FTRE $6.38
  • Average True Range (ATR)
  • USNA 1.14
  • FTRE 0.45
  • MACD
  • USNA 0.43
  • FTRE 0.21
  • Stochastic Oscillator
  • USNA 93.43
  • FTRE 83.09

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: